Your browser doesn't support javascript.
loading
Antiplatelet monotherapy after DAPT: is clopidogrel the new standard? Pros and cons.
Kim, Hyo-Soo; Kang, Jeehoon; Stefanini, Giulio; De Caterina, Raffaele.
Affiliation
  • Kim HS; Department of Internal Medicine and Cardiovascular Centre, Seoul National University Hospital, Seoul, Republic of Korea.
  • Kang J; Department of Internal Medicine and Cardiovascular Centre, Seoul National University Hospital, Seoul, Republic of Korea.
  • Stefanini G; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • De Caterina R; Humanitas Research Hospital IRCCS, Rozzano, Milan, Italy.
EuroIntervention ; 20(12): e737-e739, 2024 Jun 17.
Article in En | MEDLINE | ID: mdl-38887879
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platelet Aggregation Inhibitors / Clopidogrel Limits: Humans Language: En Journal: EuroIntervention Journal subject: ANGIOLOGIA / CARDIOLOGIA / TERAPEUTICA Year: 2024 Document type: Article Country of publication: Francia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platelet Aggregation Inhibitors / Clopidogrel Limits: Humans Language: En Journal: EuroIntervention Journal subject: ANGIOLOGIA / CARDIOLOGIA / TERAPEUTICA Year: 2024 Document type: Article Country of publication: Francia